Guanfacine for Children with Tic Disorders
Chronic Motor Tic Disorder | Chronic Vocal Tic Disorder | Tourette Syndrome
What is the purpose of this trial?
Does your child or teenager have a chronic vocal or motor tic disorder, such as Tourette’s?
Yale Child Study Center is recruiting children and teens for a study with the new extended release form of guanfacine, called Intuniv®. The treatment targets involuntary actions or vocalizations (tics) in children with tic disorders, such as Tourette Syndrome.
- 6 Years - 16 Years
Click here for detailed information about who can participate in this trial.
- Shire Pharmaceuticals
- March 2012
- September 2013
- Last Updated:
- Study HIC#: